On July 11, 2025, 180 Life Sciences Corp. announced the accelerated vesting of stock options and shares for executives, including CEO Blair Jordan, with 410,000 options and 167,576 restricted shares, tied to services rendered. This event follows previous grants made on June 17, 2025, and highlights significant executive compensation adjustments.